Research-driven botanical formulations are now available on OneLavi.com as Carmed expands U.S. distribution. The post Carmed Pharmaceuticals Launches on OneLaviResearch-driven botanical formulations are now available on OneLavi.com as Carmed expands U.S. distribution. The post Carmed Pharmaceuticals Launches on OneLavi

Carmed Pharmaceuticals Launches on OneLavi.com as Part of U.S. Expansion Strategy

2026/05/15 03:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Carmed Pharmaceuticals, a Turkey-based science-driven company specializing in standardized carvacrol-based formulations, announced that select products are now available on OneLavi.com, a curated online marketplace for beauty, health, and wellness brands. The launch represents a significant milestone in the company’s ongoing expansion into the United States market, following its previously announced plans to broaden availability through multiple digital retail channels, including Amazon.

Through OneLavi.com, U.S. consumers can now access several of Carmed’s flagship formulations, including Vacrol® Kids Spray, a carvacrol-based spray for children ages 4-11; S-Mix®, designed to support immune function; Vacrol® Capsule, a standardized carvacrol formulation; and Vacrol-M® Capsule, a multi-component botanical formulation. Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified. All formulations are developed using standardized processes to ensure consistency, reproducibility, and quality control.

Carmed states that OneLavi’s curated marketplace aligns with its long-term strategy of introducing its formulations through platforms that emphasize quality, product transparency, and wellness-focused discovery. ‘Launching on OneLavi represents an important step in making our formulations accessible to consumers in the United States,’ said Mustafa Can, Founder of Carmed Pharmaceuticals. ‘We believe curated wellness platforms provide an environment where consumers can better understand the value of standardized, research-driven formulations.’

The company’s formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science. In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to broader scientific investigation involving carvacrol-based formulations and multicomponent botanical interactions. Carmed emphasizes that this research reflects scientific investigation into botanical bioactivity and formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Carmed states that its U.S. strategy is focused on long-term brand development through scientific credibility, regulatory alignment, and expanded consumer accessibility. ‘We are excited to officially introduce Carmed to OneLavi’s wellness-focused audience,’ said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. ‘This launch supports our broader vision of building a trusted international wellness brand as we continue expanding throughout the United States.’

Consumers can learn more and shop Carmed Pharmaceuticals products at OneLavi.com: Vacrol® Kids Spray, S-Mix®, Vacrol® Capsule, and Vacrol-M® Capsule.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by Newsworthy.ai. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Carmed Pharmaceuticals Launches on OneLavi.com as Part of U.S. Expansion Strategy.

The post Carmed Pharmaceuticals Launches on OneLavi.com as Part of U.S. Expansion Strategy appeared first on citybuzz.

Market Opportunity
United Stables Logo
United Stables Price(U)
$0.9999
$0.9999$0.9999
-0.01%
USD
United Stables (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

KAIO Global Debut

KAIO Global DebutKAIO Global Debut

Enjoy 0-fee KAIO trading and tap into the RWA boom